Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand

• Main Authors: Nuntisa Chotirosniramit, Patcharaphan Sugandhavesa, Linda Aurpibul, Sunida Thetket, Natthapol Kosashunhanan, Taweewat Supindham, Panuwat Wongkulab, Quanhathai Kaewpoowat, Kanokporn Chaiklang, Oranitcha Kaewthip, Piyathida Sroysuwan, Antika Wongthanee, Hatairat Lerdsamran, Pilaipan Puthavathana, Khuanchai Suparatpinyo
• Other Authors: Chiang Mai University
• Format: Article
• Published: 2018
• Subjects: Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/14236

Background: In late 2009, the Thai Ministry of Public Health provided two million doses of the monovalent pandemic influenza H1N1 2009 vaccine (Panenza® Sanofi Pasteur), which was the only vaccine formulation available in Thailand, to persons at risk of more severe manifestations of the disease incl...